Skip to main content

Table 1 Demographic and transplant-related information of the four patients in this case series with primary central nervous system post-transplantation lymphoproliferative disorder (PCNS-PTLD) after transplant for β-thalassemia

From: Neuroimaging features of primary central nervous system post-transplantation lymphoproliferative disorder following hematopoietic stem cell transplant in patients with β-thalassemia: a case series and review of literature

Characteristic

No./median [range]

Sex

 

 Male

3

 Female

1

Age at diagnosis of PCNS-PTLD, median [range], years

6.5 [4–8]

Time from transplantation to PCNS-PTLD, median [range], months

5.5 [4–11]

Indications for transplantation

 

 Severe β-thalassemia

4

Type of transplantation

 

 Sibling (umbilical cord blood + bone marrow, HLA matched)

2

 Unrelated donor (peripheral blood, HLA matched)

1

 Sibling (peripheral blood + bone marrow, HLA6/12)

1